SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. The company announced the appointment in a press release, stating that Romano will help lead financial operations as it advances its global expansion strategy, including pursuit of U.S. Food and Drug Administration (FDA) approval for its SSi Mantra surgical robotic system.
Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. Most recently, she served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.
Based in the United States, Romano will be instrumental in guiding SS Innovations through its next phase of growth. The company is focused on making robotic surgery affordable and accessible globally, with its SSi Mantra system designed to support a variety of procedures, including cardiac surgery. The appointment signals a strategic move to strengthen financial leadership as the company seeks regulatory approvals and expands its presence in key markets.
SS Innovations, an American company headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The addition of Romano, with her extensive experience in capital raising and financial management, is expected to support these objectives.
For more details, the full press release is available at https://ibn.fm/pAqlP. Additional news and updates regarding SSII can be found in the company's newsroom at https://ibn.fm/SSII.
